Cancer–stromal cell interactions in breast cancer brain metastases induce glycocalyx-mediated resistance to HER2-targeting therapies
Marie-Anne Goyette(Dana-Farber Cancer Institute), Kornélia Polyák(Dana-Farber Cancer Institute), Gabrielle S. Tender(Stanford University), Valerie M. Weaver(University of California, San Francisco), Callahan M. Wilde(Dana-Farber Cancer Institute), Klothilda Lim(Dana-Farber Cancer Institute), Xintao Qiu(Dana-Farber Cancer Institute), Marco Seehawer(Brigham and Women's Hospital), Jun Nishida(Brigham and Women's Hospital), Jason J. Northey(University of Alberta), Stephanie Zhao(Oregon Health & Science University), Henry W. Long(Dana-Farber Cancer Institute), Zheqi Li(Sun Yat-sen University), Alanna L. Pyke(Dana-Farber Cancer Institute), Carolyn R. Bertozzi(Howard Hughes Medical Institute), Carolyn R. DePinho(Dana-Farber Cancer Institute), Nicholas M. Riley(University of Washington), Rong Li(Dana-Farber Cancer Institute), Laura E. Stevens(Brigham and Women's Hospital)
Cited by 28
Related Papers
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
|Nature reviews. Cancer|2009|3.3k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k
A model for p53-induced apoptosis
|Nature|1997|2.5k